Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2015-01-09)Premium Content

Novo Nordisk (NVO)

2015-03-04@11:30:05 ET
From Denmark to Mozambique: Health on Two Wheels (TBL)

2015-03-04@09:44:10 ET
Global Biologics and Biosimilars Industry Report 2015 (MTO)

2015-03-04@05:22:12 ET
USPTO ISSUES TRADEMARK: VICVASIA (ABW)

2015-03-04@05:01:51 ET
USPTO ISSUES TRADEMARK: VICTSATIO (ABW)

2015-03-03@08:22:58 ET
Bottom 5 Companies in the Pharmaceuticals Industry with the Lowest Relative Performance (SCMP, NVS, SNY, NVO, RHHBY) (F70)

2015-03-03@06:10:24 ET
Non-Alcoholic Steatohepatitis Therapeutics Pipeline Review 2015 - Analysis of 32 Companies & 53 Drug Profiles (MTO)

2015-03-02@08:48:22 ET
Novo Nordisk A/S: Novo Nordisk A/S - Share repurchase programme (PMZ)

2015-03-02@08:46:13 ET
Novo Nordisk A/S: Novo Nordisk A/S - Share repurchase programme (HUG)

2015-03-02@08:00:02 ET
Novo Nordisk, Takeda, Servier, Celgene Among Top Sponsors Rated by Investigative Sites in New CenterWatch Survey (BIZ)

2015-03-01@15:15:44 ET
Round-table meet on diabetes held (ABW)

2015-02-26@18:39:00 ET
(CNW)

2015-02-26@08:02:18 ET
USPTO ISSUES TRADEMARK: NOVONET (ABW)

2015-02-25@21:52:52 ET
US Patent Issued to Novo Nordisk on Feb. 24 for "Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids" (Danish Inventors) (ABW)

2015-02-23@08:10:31 ET
Novo Nordisk is Among the Companies in the Diversified Metals & Mining Industry with the Best Relative Performance (NVO, BLT, CS, BPL, VRX) (F70)

2015-02-23@06:13:34 ET
Novo Nordisk A/S - Share repurchase programme (PMZ)

2015-02-23@06:06:28 ET
Novo Nordisk A/S - Share repurchase programme (HUG)

2015-02-20@17:08:52 ET
Watch for Novo Nordisk to Potentially Pullback After Gaining 5.27% Yesterday (PSM)

2015-02-20@14:06:37 ET
Trading Higher on Heavy Volume are Shares of Novo Nordisk on 1.9x Above-Average Volume (NVO) (F82)

2015-02-20@11:59:13 ET
Emisphere Highlights Positive Phase 2 OG217SC Data From Eligen(R) Licensee Novo Nordisk (PMZ)

2015-02-20@11:18:07 ET
Novo Nordisk Makes a Move: Up 4.2% (F77)